
SynBioBeta 2026 Speaker
Joy Jiao
OpenAI
Research Lead
Joy leads the life sciences research team at OpenAI. The goal of the team is to accelerate basic research and drug discovery, by operating across the model training stack to improve model capabilities from molecules to organisms. At OpenAI, Joy previously worked on model safety, personalization, search, and representation learning. She holds a PhD in Systems Biology from Harvard, where she studied the in-patient evolution of cancer cells during immunotherapy as well as the evolution of antibiotic resistance.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


